124 related articles for article (PubMed ID: 1380148)
1. CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small cell lung cancer.
Masuda N; Fukuoka M; Furuse K
Oncology; 1992; 49 Suppl 1():19-24. PubMed ID: 1380148
[TBL] [Abstract][Full Text] [Related]
2. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
Furuse K; Fukuoka M; Nishiwaki Y; Kurita Y; Watanabe K; Noda K; Ariyoshi Y; Tamura T; Saijo N
J Clin Oncol; 1998 Jun; 16(6):2126-32. PubMed ID: 9626212
[TBL] [Abstract][Full Text] [Related]
3. Dose-intensive chemotherapy in extensive-stage small cell lung cancer.
Fukuoka M; Masuda N; Takada M; Kodama N; Kawahara M; Furuse K
Semin Oncol; 1994 Feb; 21(1 Suppl 1):43-7. PubMed ID: 7512276
[No Abstract] [Full Text] [Related]
4. Dose-intensive chemotherapy in extensive-stage small-cell lung cancer.
Negoro S; Masuda N; Furuse K; Saijo N; Fukuoka M
Cancer Chemother Pharmacol; 1997; 40 Suppl():S70-3. PubMed ID: 9272138
[TBL] [Abstract][Full Text] [Related]
5. CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.
Fukuoka M; Masuda N; Negoro S; Matsui K; Yana T; Kudoh S; Kusunoki Y; Takada M; Kawahara M; Ogawara M; Kodama N; Kubota K; Furuse K
Br J Cancer; 1997; 75(2):306-9. PubMed ID: 9010043
[TBL] [Abstract][Full Text] [Related]
6. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
Yanagawa H; Bando H; Takishita Y
Anticancer Res; 1995; 15(2):613-6. PubMed ID: 7539241
[TBL] [Abstract][Full Text] [Related]
7. Weekly CODE chemotherapy with recombinant human granulocyte colony-stimulating factor for relapsed or refractory small cell lung cancer.
Sato K; Tsuchiya S; Minato K; Sunaga N; Ishihara SI; Makimoto T; Naruse I; Hoshino H; Watanabe S; Saitoh R; Mori M
Oncol Rep; 2000; 7(5):1135-9. PubMed ID: 10948352
[TBL] [Abstract][Full Text] [Related]
8. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.
Murray N; Livingston RB; Shepherd FA; James K; Zee B; Langleben A; Kraut M; Bearden J; Goodwin JW; Grafton C; Turrisi A; Walde D; Croft H; Osoba D; Ottaway J; Gandara D
J Clin Oncol; 1999 Aug; 17(8):2300-8. PubMed ID: 10561291
[TBL] [Abstract][Full Text] [Related]
9. Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working Party.
Thatcher N; Clark PI; Smith DB; Anderson H; Girling DJ; Machin D; Stephens RJ; Lallemand G; Jenkins B
Clin Oncol (R Coll Radiol); 1995; 7(5):293-9. PubMed ID: 8580054
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
11. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
[TBL] [Abstract][Full Text] [Related]
12. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
Woll PJ; Hodgetts J; Lomax L; Bildet F; Cour-Chabernaud V; Thatcher N
J Clin Oncol; 1995 Mar; 13(3):652-9. PubMed ID: 7533825
[TBL] [Abstract][Full Text] [Related]
13. [Dose intensity chemotherapy in lung cancer].
Takada M; Fukuoka M; Negoro S; Masuda N; Kudo S
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2005-12. PubMed ID: 1699498
[TBL] [Abstract][Full Text] [Related]
14. Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer.
Murray N; Shah A; Osoba D; Page R; Karsai H; Grafton C; Goddard K; Fairey R; Voss N
J Clin Oncol; 1991 Sep; 9(9):1632-8. PubMed ID: 1651995
[TBL] [Abstract][Full Text] [Related]
15. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
Pujol JL; Douillard JY; Rivière A; Quoix E; Lagrange JL; Berthaud P; Bardonnet-Comte M; Polin V; Gautier V; Milleron B; Chomy F; Chomy P; Spaeth D; Le Chevalier T
J Clin Oncol; 1997 May; 15(5):2082-9. PubMed ID: 9164221
[TBL] [Abstract][Full Text] [Related]
16. Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer.
Kubota K; Nishiwaki Y; Kakinuma R; Hojo F; Matsumoto T; Ohmatsu H; Sekine I; Yokozaki M; Goto K; Ebi N; Kodama T
J Clin Oncol; 1997 Jan; 15(1):292-6. PubMed ID: 8996155
[TBL] [Abstract][Full Text] [Related]
17. The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
Urban T; Chastang C; Lebas FX; Duhamel JP; Adam G; Darse J; Bréchot JM; Lebeau B
Cancer; 1999 Dec; 86(11):2238-45. PubMed ID: 10590363
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.
Schiller JH; Kim K; Hutson P; DeVore R; Glick J; Stewart J; Johnson D
J Clin Oncol; 1996 Aug; 14(8):2345-52. PubMed ID: 8708727
[TBL] [Abstract][Full Text] [Related]
19. Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.
Hanauske AR; Korfel A; Perker M; Heinrich B; Schwab G; Graf M; Depenbrock H; Höffken G; Kreuser ED; Thiel E; Zwingers T; Berdel WE
Oncology; 1997; 54(5):363-70. PubMed ID: 9260596
[TBL] [Abstract][Full Text] [Related]
20. Weekly dose-intensive chemotherapy in patients with small-cell lung cancer: a pilot study.
Kudoh S; Fukuoka M; Negoro S; Tanaka H; Kusunoki Y; Matsui K; Masuda N; Takifugi N; Itoh K; Nishioka M
Am J Clin Oncol; 1992 Feb; 15(1):29-34. PubMed ID: 1372463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
